Clinical Trials Logo

Obesity clinical trials

View clinical trials related to Obesity.

Filter by:

NCT ID: NCT04297059 Completed - Childhood Obesity Clinical Trials

The Ajyal Salima Longitudinal Study to Prevent Childhood Obesity

Start date: September 1, 2014
Phase: N/A
Study type: Interventional

The study was carried out to determine the long-term effectiveness of a school-based intervention programme when implemented over 2 years and its sustained effect one year later.

NCT ID: NCT04296721 Completed - Obesity Clinical Trials

Cost-effectiveness Study of a Lifestyle Change Program for the Treatment of OSA and Obesity: Hospital-Primary Care.

SPP-1
Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Obesity is the main risk factor for Obstructive Sleep Apnea (OSA). Nasal CPAP is the standard treatment for OSA, but since weight-loss programs are not usually offered to OSA patients, the root causes of their illness and its comorbidities are not treated. There is some evidence regarding improvements in OSA after weight reduction but whether weight reduction programs are cost-efficient has not as yet been addressed. OBJECTIVE: To determine whether an intensive weight-loss program, carried out in a project combining hospital and primary care levels, is cost-effective in the medium and long term for the treatment of obese patients with severe OSA undergoing CPAP treatment. More concretely, our objective is to demonstrate whether this program achieves sufficient improvement in OSA to allow a reduction <30/h in the apnea-hypopnea index in at least 25%, improving their metabolic profile and central obesity. METHOD: A prospective, randomized, controlled study. Control group: standard dietary recommendations. Intervention group: 0-3 months very low calorie diet, 15 days substituting three meals for low calorie shakes, from 15 to 120 days substituting 1 meal and from 120 days to 12 months on a low calorie diet while starting a progressive exercise program. Recommendations for good sleep habits will be given. The program will be carried out through group and individual sessions with the hospital dietician. After 3 months: group sessions with a nurse in the basic area. Group sessions led by hospital dietician. From 3 to 12 months: group sessions led by primary care nurse. MEASUREMENTS: At the beginning, at 3 and at 12 months: two-night home respiratory polygraph, actigraphy, anthropometric and blood analysis data including metabolic syndrome and inflammatory markers, and health related quality of life questionnaires. Direct and indirect costs of treatments, outpatient's consultations, incomes, emergency visits and patients' travel costs to medical centers.

NCT ID: NCT04296669 Completed - Obesity Clinical Trials

Stand Out in Class: Reducing Sitting Time in the Classroom Environment

SOIC2
Start date: August 20, 2015
Phase: N/A
Study type: Interventional

The primary aim of this study is to examine the effectiveness of incorporating manually adjustable sit-stand desks in the classroom environment of 9-10 year olds in reducing sedentary behaviour at school during a full school year. Secondary aims include evaluating the effects of the intervention on health and learning outcomes as well as comparing the impact of full classroom allocation of sit-stand desks to a classroom of partial sit-stand desk allocation.

NCT ID: NCT04294238 Completed - Obesity Clinical Trials

The Function and Proteome Alteration of HDL Subclass After Aerobic Exercise

Start date: January 30, 2018
Phase: N/A
Study type: Interventional

Obesity is one of the most important risk factors for cardiovascular disease (CVD). HDL protein composition can be altered without a change in cholesterol content. Alteration of the HDL proteome can result in dysfunctional HDL particles with reduced ability to protect against CVD. The aim of this study was to evaluate the influence of moderate aerobic exercise on HDL protein composition and its related function. This was a self-control study including 6 inactive male youths with abdominal obesity. HDL functions and its associations with proteome alteration would be analysized.

NCT ID: NCT04293731 Completed - Obesity Clinical Trials

Smectite Gel and Probiotic for Obesity and Insulin Resistance

Start date: November 1, 2018
Phase: N/A
Study type: Interventional

Probiotics are defined as live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Smectite is a natural silicate clay belonging to the dioctahedral smectite class formed from aluminomagnesium silicate. It is not absorbed from the gastrointestinal tract, but binds to intestinal mucous, forms multilayer structure with high plastic viscosity and powerful coating properties hence preserving integrity of the mucus, and has the ability to absorb directly bacterial toxins, bacteria, viruses and bile salts. The current study aim was to conduct placebo-controlled randomize clinical trial for the efficiency of a combination of multiprobiotics with smectite (Symbiter-Forte formulation) as an adjunction to the standard anti-diabetic therapy on IR, glycemic control parameters, β-cells functional activity, anthropometric parameters and markers of a chronic systemic inflammatory response in type 2 diabetes patients.

NCT ID: NCT04293367 Completed - Obesity Clinical Trials

Fuel Utilization, Diet Composition, and Exercise in African American Women

Start date: June 1, 2009
Phase: N/A
Study type: Interventional

African American women have a high prevalence of obesity and type 2 diabetes and do not optimally burn fat and carbohydrates in response to changes in these nutrients in their diets. This research project seek to determine if high intensity interval training (HIIT) exercise training can help healthy, but inactive, premenopausal, non-diabetic women increase their bodies' use of fat and carbohydrates when provided with a high fat or low fat diets. In this study, investigators will measure the rate at which fat is burned in response to weight maintaining low-fat and high-fat diets and how exercise may affect these responses.

NCT ID: NCT04293055 Completed - Obesity Clinical Trials

Phone Coaching for Weight Loss Maintenance

Start date: March 4, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether weight loss maintenance can be improved by providing individuals with 4 consecutive weeks of phone coaching during the maintenance period. Individuals who previously achieved and maintained a >=5% weight loss in a 1-year behavioral weight loss program will be provided with a low-intensity maintenance intervention. Some individuals will be selected to receive phone coaching. Assessments of weight, physical activity, and other weight-related behaviors will occur at baseline, 6 months, and 1 year.

NCT ID: NCT04292236 Completed - Obesity Clinical Trials

The Effect of Food Supplements on Food Intake and Gut Hormone Levels

Start date: February 22, 2019
Phase: N/A
Study type: Interventional

When a meal is eaten, nutrients activate the release of hormones from the bowel into the blood stream. Normally there is a large amount of hormone released, which tells the brain that an individual is full and to stop eating. When people gain weight and become overweight or obese, these hormone signals are reduced, resulting in these people eating more and gaining more weight. This study is investigating mechanisms which may break this cycle by using particular nutrients to restore reduced hormone levels.

NCT ID: NCT04291391 Completed - Obesity Clinical Trials

The Alberta NutrIMM Study - Nutrition and Immunity

NutrIMM
Start date: September 1, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effect of body weight, diet, and high blood sugar levels, under controlled feeding conditions, on immune function in individuals with and without obesity. This study will be a non-randomized, four-arm parallel group, clinical trial under controlled feeding conditions (4-week nutritional intervention using a North American-type diet). A sample size of n=128 participants will be allocated into one of the following groups: - Individuals without obesity and normoglycemia (NG) (Lean-NG) - Individuals with obesity and normoglycemia (Obese-NG) - Individuals with obesity and glucose intolerance (GI) (Obese-GI) - Individuals with obesity and type 2 diabetes (T2D) (Obese-T2D) The following outcomes will be analyzed: - Immune cell function (ex-vivo cytokine production after stimulation with mitogen and T cell proliferation); - Immune cell phenotypes; - Systemic inflammation (C-reactive protein and plasma cytokines); - Glucose, insulin, glycated hemoglobin (HbA1c), and lipids; - Fatty acids and phospholipds composition in plasma and red blood cells membrane.

NCT ID: NCT04291365 Completed - Obesity Clinical Trials

Alternative Blood Pressure Measurements in OB Patients

Start date: March 1, 2020
Phase: N/A
Study type: Interventional

The incidence of obesity has been increasing worldwide. In women with obesity, the anthropometric differences in the distribution of subcutaneous tissue can make accurate measurement of blood pressure difficult. A large upper arm circumference can prevent the use of a brachial artery blood pressure cuff and often prompts the use of alternative methods for blood pressure measurement, including measurements on the wrist or forearm. Outside of the obstetric population, there is evidence that if measurement of the blood pressure at the upper arm is not possible then measurement at the wrist can be used. Despite this evidence in non-pregnant patients, there is limited evidence in pregnancy regarding the accuracy of blood pressure measurements on the forearm or wrist. Accurate measurement of blood pressure is especially important in pregnancy to allow for prompt treatment of severe hypertension and for accurate diagnosis of hypertensive disorders of pregnancy. Error in measurement could lead to iatrogenic preterm birth or under treatment of severe hypertension, both which can lead to severe maternal and fetal morbidity and mortality. Additionally, it is biologically plausible that an increase in subcutaneous edema and vascular changes in pregnancy could lead to a larger discrepancy in blood pressure measurements between upper arm, forearm and wrist measurements. Due to the increasing epidemic of obesity and the increasing need for accurate alternative blood pressure measurements the investigators propose a prospective observational study of pregnant women ≥18 years old admitted to labor and delivery for any indication or seen for prenatal care in OBGYN clinic. A total of 20 women in each BMI class (normal, overweight (25-29.9), class 1 (30-34.9), class 2 (35-39.9), class 3 (>40) will be enrolled (100 total). Participation will include a total of 9 blood pressure measurements, biometric measurements on the patient's upper arm, forearm, and wrist and a brief questionnaire. The investigators hypothesize that there will be a discrepancy between blood pressure measurements on the upper arm and forearm or wrist.